Drawing for SETALUM

USPTO serial 79215381

SETALUM

Reviewed by CopyMark Law Group

Reg. 5658408Status 709
Filing date
Status date
Registration date
Jan 22, 2019
Examiner
O'BRIEN, JENNIFER LYNN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SETALUM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Dmitriy O. Makarov

Dmitriy O. Makarov IPHORGAN LTD.195 Arlington Heights Rd, Suite #125Buffalo Grove, IL 60089-1768UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Polymers and prepolymers for medical, surgical, dental, pharmaceutical, cosmetic or veterinary use in the nature of adhesives, namely, medical adhesives for binding internal tissue, medical adhesive tape, medical adhesives for binding wounds, medical adhesives in the form of polymerized liquid for medical and surgical purpose to attach devices to tissue, medical adhesives in the form of polymerized liquid for medical purposes to attach devices together, drug delivery agents in the form of medical adhesives that facilitate the delivery of pharmaceutical preparations, Sealants being medical adhesive in the form of polymerized liquid, namely, medical sealants to avoid the leakage of biological fluids or air, medical sealants to repair fissures or augment sutures or staples, filler in the nature of medicinal adhesives and surgical glue, namely, urogenital fillers and gastrointestinal fillers, fillers to fill hard and soft tissue defects, fillers to augment tissue and create volume, namely, dermal filler and breast implants fillers; adhesive products for medical, surgical, dental, pharmaceutical, cosmetic or veterinary use to bind, protect, fill and/or reconstruct internal and/or external tissue, namely, medical adhesives for binding internal tissue, medical adhesive tape, medical adhesives for binding wounds; drug delivery agents in the form of medical adhesives that facilitate the delivery of pharmaceutical preparations; chemical and biological preparations for medical, pharmaceutical, cosmetic or veterinary use, namely, for the treatment of cardio-vascular diseases, digestive disorders, pulmo-thoracic diseases, neurology diseases, orthopedic disorders, dental applications in the nature of anti-cavity dental coating preparations containing fluoride and as drug delivery agents in the form of implants, biodegradable films that facilitate the delivery of pharmaceutical preparationsSECTION 71 - CANCELLED—
010Medical, surgical, cosmetic, veterinary and dental apparatus, instruments and devices, namely, disposable syringes, as well as open surgery, minimally invasive, interventional, endoscopic, and laparoscopic surgical devices and instruments and surgical robots for use in cardiac, vascular, thoracic, gastrointestinal, neuro, urology, orthopedic, maxilo-facial, plastic and ophthalmological surgeries; suture material; prostheses, namely, medical prostheses for tissue repair and reconstruction, dental prostheses, bone prostheses, biodegradable bone fixation implants; implants consisting of artificial materials; syringes for medical, surgical or dental use and applicators being a component part of syringes for medical, surgical and dental applications, sold as a unit; surgical lamps; lamps for medical use, namely, polymerization light sources for medical applications in the nature of light emitting diode (LED) apparatus for lighting, incorporated into medical instruments and ultraviolet lamps for medical purposes; heating lamps for medical applications; dental care lamps, namely, polymerization light sources for dental applications in the nature of light emitting diode (LED) apparatus for lighting, incorporated into medical instruments and ultraviolet lamps for medical purposesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 8, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 8, 2025C71TCANCELLED SECTION 71—
Jan 22, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 2, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 31, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 10, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 10, 2019FIMPFINAL DISPOSITION PROCESSED—
Apr 22, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 22, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 6, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 6, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 2, 2018GPNXNOTIFICATION PROCESSED BY IB—
Oct 17, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 17, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Oct 17, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 4, 2018PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 1, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 18, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Sep 18, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 18, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 18, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 21, 2018GNS1NOTIFICATION OF SUBSEQUENT FINAL EMAILED—
Aug 21, 2018GNCFCONTINUATION OF FINAL REFUSAL E-MAILED—
Aug 21, 2018CNCFACTION CONTINUING A FINAL - COMPLETED—
Jul 23, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 23, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 23, 2018ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Feb 7, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 7, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 7, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 23, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 23, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 22, 2018ALIEASSIGNED TO LIE—
Jan 5, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 13, 2017RFNTREFUSAL PROCESSED BY IB—
Sep 22, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 22, 2017RFRRREFUSAL PROCESSED BY MPU—
Sep 20, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 19, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 12, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 11, 2017DOCKASSIGNED TO EXAMINER—
Sep 6, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 31, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance